'Toxicity profile' diaporamas de présentation

Chemotherapy for Metastatic Colon Cancer

Scott Berry Sunnybrook Health Sciences Centre. Chemotherapy for Metastatic Colon Cancer. Where Were We Until 2000?. O. F. HN. O. N H. 5-FU. oxaliplatin. irinotecan. C. H. 3. C. H. O. 2. O. N. N. N. O. C. O. O. N. H. O. C. H. C. H. 2. 3. NH 2. O. C. Pt. O.

1.44k views • 83 slides

Ethical Issues in Phase I Oncology Trials

Ethical Issues in Phase I Oncology Trials. Sandra L. Alfano, Pharm.D., CIP Chair, Human Investigation Committee-I and III. Objectives. Understand the ethical foundations of human subjects research

585 views • 41 slides

Targeting Glioblastoma: EGFR and Novel Approaches to Therapy

Targeting Glioblastoma: EGFR and Novel Approaches to Therapy. Glioblastoma: The Current State of Affairs. No Improvement With Temozolomide Dose Intensification or Treatment Prolongation. Treatment at Recurrence. Glioblastoma: Improving Outcomes.

918 views • 32 slides

610 views • 32 slides

Co-authors

A phase I study on the combination of neoadjuvant radiotherapy plus pazopanib in patients with locally advanced soft tissue sarcoma of the extremities CTOS 2014 Rick Haas Department of Radiotherapy, The Netherlands Cancer Institute Amsterdam. Co-authors. Disclosure.

322 views • 32 slides

Toxicities and clinical issues with Immunotherapies

243 views • 24 slides